![glp 1 depression GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] does glp 1 help depression](https://www.preprints.org/frontend/picture/ms_xml/manuscript/c9c3cd16d3db64faa79714c50b5bb790/preprints-181961-g001.png)
glp 1 depression GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] does glp 1 help depression
Description
Manufactured in a cGMP-certified facility.
![glp 1 depression GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] does glp 1 help depression](https://cdn2.caymanchem.com/cdn/cms/caymanchem/PublishingImages/Lists/NewsItems/AllItems/Actions%20of%20GLP-1%20and%20GIP.png)
Compare early results with Wegovy and Mounjaro.
![glp 1 depression GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] does glp 1 help depression](https://www.diabetesincontrol.com/wp-content/uploads/2026/01/glp1-depression-brain-therapy-concept.png)
(1)These statements have not been evaluated by the Food and Drug Administration
![glp 1 depression GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] does glp 1 help depression](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-024-75965-2/MediaObjects/41598_2024_75965_Fig1_HTML.png)
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, are widely used in the treatment of metabolic disorders, including type 2 diabetes (T2D) and obesity
![glp 1 depression GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] does glp 1 help depression](https://media.post.rvohealth.io/wp-content/uploads/sites/3/2025/03/news-roundup-20240313-1296x728-header-1024x575.jpg)
7.40.8 Eq/min/gkw)
![glp 1 depression GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] does glp 1 help depression](https://www.thelancet.com/cms/10.1016/S2215-0366(26)00014-3/asset/c6c68f71-1303-4dbd-81fc-c7e57d64925d/main.assets/gr2_lrg.jpg)
Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women.
